Description
PEA With Levagen Capsules
Disclaimer: The compounds described on this page are intended for laboratory research use only and are not approved for human consumption.
Overview of PEA
PEA (Palmitoylethanolamide) is a fatty acid amide that belongs to the group of N-acylethanolamines. It naturally occurs in the tissues of research subjects as a response to cellular stress. PEA is studied for its potential role in modulating inflammatory pathways and interacting with the endocannabinoid system. It is investigated for applications in areas such as pain signaling, immune responses, and neuroinflammation.
| Section | Details |
| CAS Number | 544-31-0 |
| Molar Mass | 299.5 g/mol |
| Chemical Formula | C18H37NO2 |
| IUPAC Name | N-(2-hydroxyethyl)hexadecanamide |
| Synonyms | Palmitoylethanolamide, Palmidrol, Palmitoyl ethanolamide, Hydroxyethylpalmitamide ® |
| Ingredients / Composition | PEA with Levagen Capsules contains Palmitoylethanolamide (PEA) with a purity of 98.8%. They also contain Levagen with a purity of 99.1%, both meeting the set quality standards. |
| Shelf Life | 12-24 months |
| Storage Instructions | Store at 20 to 25 °C. |
| Disclaimer | This product is intended for laboratory research purposes only. It is not approved for human consumption or use. |
Why Consider PEA with Levagen Capsules for Research?
Researchers may consider PEA with Levagen Capsules based on its intended research application, available specifications, and supporting documentation.
– Our PEA with Levagen is verified through advanced HPLC testing.
– The assay results confirm 98.8% for PEA and 99.1% for Levagen.
– PEA is formulated in capsule form for convenience in research.
– The heavy metals (As, Pb, Cd, Hg) tested in this product were found below 5 ppm total.
– The residual solvents are present at 0.1%, within the 0.5% specification.
– Endotoxin levels are below 0.5 EU/mg, and microbial growth was not detected.
Researchers may consider PEA with Levagen Capsules based on its intended research application, available specifications, and supporting documentation.
Frequently Asked Questions (FAQs)
Is Levagen the same as PEA?
Levagen® is a trademarked, purified form of palmitoylethanolamide (PEA). It is PEA, but produced to ensure high purity and consistency in research.
Is PEA legal?
How long does it take for PEA to work?
Some studies report the results of PEA in research models within hours or days. In other reports, effects are observed over several weeks. So, the time PEA takes to show effects depends on the research model and the endpoints of the study.
What are the effects of PEA in research studies?
PEA has shown effects such as reducing inflammation, supporting immune function, and lowering pain signals in research.
Do PEA with Levagen capsules show higher bioavailability in research compared to standard PEA?
Yes. PEA with Levagen capsules shows higher bioavailability. Studies show that Levagen capsules, which use LipiSperse technology, are absorbed better in research models than standard PEA.
What role does Levagen play in studies on sleep and circadian rhythm regulation?
Levagen (a branded form of PEA) has shown the ability to help reduce the time it takes to fall asleep. It may also improve alertness upon waking and support circadian rhythm regulation in research subjects.
Are there any side effects of PEA in research models?
PEA has shown a good safety profile. Its side effects are rare and include occasional mild gastrointestinal symptoms and isolated non-dose-dependent findings in long-term studies.
Where can readers find vendor information for PEA with Levagen Capsules?
The linked vendor provides research information and affiliate purchasing pathways but does not directly sell, manufacture, warehouse, or ship PEA with Levagen Capsules. Readers should assess third-party suppliers independently and review available identity, purity, and batch-testing documentation. Payment methods and checkout terms are determined by the selected vendor.
IML Affiliate Disclosure
Some links on IML may connect readers with third-party suppliers through affiliate arrangements. IML may receive compensation from qualifying transactions at no additional cost to the reader, but the third-party supplier remains responsible for the actual sale, fulfillment, and product documentation.
